Study of SYS6020 in BCMA-positive Multiple Myeloma
NCT06359509
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
NOT_YET_RECRUITING
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Multiple Myeloma
Interventions
BIOLOGICAL:
BCMA Targeted CAR T-cells
Sponsor
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology